Advances in antimicrobial peptide immunobiology

被引:247
作者
Yount, Nannette Y.
Bayer, Arnold S.
Xiong, Yan Q.
Yeaman, Michael R. [1 ]
机构
[1] Harbor UCLA Med Ctr, Div Infect Dis, Torrance, CA 90509 USA
[2] Harbor UCLA Med Ctr, St Johns Cardiovasc Res Ctr, Los Angeles Biomed Res Ctr, Torrance, CA 90502 USA
[3] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90024 USA
关键词
peptide; host defense; mechanisms; resistance; immunobiology;
D O I
10.1002/bip.20543
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Antimicrobial peptides are ancient components of the innate immune system and have been isolated from organisms spanning the phylogenetic spectrum. Over an evolutionary time span, these peptides have retained potency, in the face of highly mutable target microorganisms. This fact suggests important coevolutionary influences in the host-pathogen relationship. Despite their diverse origins, the majority of antimicrobial peptides have common biophysical parameters that are likely essential for activity, including small size, cationicity, and amphipathicity. Although more than 900 different antimicrobial peptides have been characterized, most can be grouped as belonging to one of three structural classes: (1) linear, often of a-helical propensity; (2) cysteine stabilized, most commonly conforming to beta-sheet structure; and (3) those with one or more predominant amino acid residues, but variable in structure. Interestingly, these biophysical and structural features are retained in ribosomally as well as nonribosomally synthesized peptides. Therefore, it appears that a relatively limited set of physicochemical features is required for antimicrobial peptide efficacy against a broad spectrum of microbial pathogens. During the past several years, a number of themes have emerged within the field of antimicrobial peptide immunobiology. One developing area expands upon known microbicidal mechanisms of antimicrobial peptides to include targets beyond the plasma membrane. Examples include antimicrobial peptide activity involving structures such as extracellular polysaccharide and cell wall components, as well as the identification of an increasing number of intracellular targets. Additional areas of interest include an expanding recognition of antimicrobial peptide multifunctionality, and the identification of large antimicrobial proteins, and antimicrobial peptide or protein fragments derived thereof. The following discussion highlights such recent developments in antimicrobial peptide immunobiology, with an emphasis on the biophysical aspects of host-defense polypeptide action and mechanisms of microbial resistance. (c) 2006 Wiley Periodicals, Inc.
引用
收藏
页码:435 / 458
页数:24
相关论文
共 194 条
[1]   FALL-39, A PUTATIVE HUMAN PEPTIDE ANTIBIOTIC, IS CYSTEINE-FREE AND EXPRESSED IN BONE-MARROW AND TESTIS [J].
AGERBERTH, B ;
GUNNE, H ;
ODEBERG, J ;
KOGNER, P ;
BOMAN, HG ;
GUDMUNDSSON, GH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (01) :195-199
[2]   Pathogen recognition and innate immunity [J].
Akira, S ;
Uematsu, S ;
Takeuchi, O .
CELL, 2006, 124 (04) :783-801
[3]   Ascaris nematodes from pig and human make three antibacterial peptides:: isolation of cecropin P1 and two ASABF peptides [J].
Andersson, M ;
Boman, A ;
Boman, HG .
CELLULAR AND MOLECULAR LIFE SCIENCES, 2003, 60 (03) :599-606
[4]   The role of ABC transporters from Aspergillus nidulans in protection against cytotoxic agents and in antibiotic production [J].
Andrade, AC ;
Van Nistelrooy, JGM ;
Peery, RB ;
Skatrud, PL ;
De Waard, MA .
MOLECULAR AND GENERAL GENETICS, 2000, 263 (06) :966-977
[5]   The TRK1 potassium transporter is the critical effector for killing of Candida albicans by the cationic protein, Histatin 5 [J].
Baev, D ;
Rivetta, A ;
Vylkova, S ;
Sun, JNN ;
Zeng, GF ;
Slayman, CL ;
Edgerton, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (53) :55060-55072
[6]   CRYSTAL-STRUCTURE OF INTERLEUKIN-8 - SYMBIOSIS OF NMR AND CRYSTALLOGRAPHY [J].
BALDWIN, ET ;
WEBER, IT ;
STCHARLES, R ;
XUAN, JC ;
APPELLA, E ;
YAMADA, M ;
MATSUSHIMA, K ;
EDWARDS, BFP ;
CLORE, GM ;
GRONENBORN, AM ;
WLODAWER, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (02) :502-506
[7]   The lipopolysaccharide of Bordetella bronchiseptica acts as a protective shield against antimicrobial peptides [J].
Banemann, A ;
Deppisch, H ;
Gross, R .
INFECTION AND IMMUNITY, 1998, 66 (12) :5607-5612
[8]   Staphylococcus aureus menD and hemB mutants are as infective as the parent strains, but the menadione biosynthetic mutant persists within the kidney [J].
Bates, DM ;
von Eiff, C ;
McNamara, PJ ;
Peters, G ;
Yeaman, MR ;
Bayer, AS ;
Proctor, RA .
JOURNAL OF INFECTIOUS DISEASES, 2003, 187 (10) :1654-1661
[9]   Mode of action of lipid II-targeting lantibiotics [J].
Bauer, R ;
Dicks, LMT .
INTERNATIONAL JOURNAL OF FOOD MICROBIOLOGY, 2005, 101 (02) :201-216
[10]   Transposon disruption of the complex INADH oxidoreductase gene (snoD) in Staphylococcus aureus is associated with reduced susceptibility to the microbicidal activity of thrombin-induced platelet microbicidal protein 1 [J].
Bayer, AS ;
McNamara, P ;
Yeaman, MR ;
Lucindo, N ;
Jones, T ;
Cheung, AL ;
Sahl, HG ;
Proctor, RA .
JOURNAL OF BACTERIOLOGY, 2006, 188 (01) :211-222